The University of Kentucky Markey Cancer Foundation was on hand as the UK Markey Cancer Center hosted its inaugural Precision Medicine Symposium on March 23, 2017 at the Hyatt Regency in downtown Lexington. The purpose of the one-day conference was to educate healthcare providers, especially those with a focus on cancer, on how to utilize precision medicine in clinical practice.
Precision, or personalized, medicine focuses on an understanding of genetic mutations in order to select the best treatment approach to an individual’s cancer. It was one of the recommendations set forth by the White House Cancer Moonshot’s Blue Ribbon Panel.
Presentations at the Markey Cancer Center Precision Medicine Symposium included clinical trials, Markey’s new state-of-the-art Molecular Tumor Board, oncogenomic testing and more. There were also breakout sessions aimed at allowing attendees to meet and ask questions about how the topics covered affect their individual areas of focus within healthcare.
Read more at UKNow.